IL‐12 immunotherapy of murine leukaemia: comparison of systemic versus gene modified cell therapy
IL‐12 immunotherapy of murine leukaemia: comparison of systemic versus gene modified cell therapy
About this item
Full title
Author / Creator
Publisher
Oxford, UK: Blackwell Publishing Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Blackwell Publishing Ltd
Subjects
More information
Scope and Contents
Contents
The ability of IL‐12 to initiate anti‐leukaemia immune responses has been well established; however clinical outcomes fail to recapitulate the therapeutic benefits observed in the laboratory. To address this, we compared two systems of IL‐12 therapy that elicit protective immune responses against the murine acute lymphoblastic leukaemia (ALL) cell...
Alternative Titles
Full title
IL‐12 immunotherapy of murine leukaemia: comparison of systemic versus gene modified cell therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6512371
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6512371
Other Identifiers
ISSN
1582-1838
E-ISSN
1582-4934
DOI
10.1111/j.1582-4934.2008.00412.x
